Author

Margarethe Heiden

Observed names: Heiden, Margarethe, M Heiden, M. Heiden, treatment of virus suspensions at 56 °C for 30 min reduced virus titres significantly compared to an incubation at 25 °C. Virus derived from serum or from cell culture was resistant against treatment with detergents (5% Tween 20) or lipid solvents (chloroform) [

Institution: Paul Ehrlich Institut

Observed institutions: University Hospital Bonn, German Red Cross, Universitätsklinikum des Saarlandes, Helios Klinikum Krefeld, Heinrich Heine University Düsseldorf, Ludwig-Maximilians-Universität München, Paul Ehrlich Institut, Saarland University

OpenAlex ID: A5109554290

Orthopox Viruses: Infections in Humans

2010 · Georg Pauli, Johannes Blümel, et al. · Transfusion Medicine and Hemotherapy · 115

PDF

The German Haemovigilance System–reports of serious adverse transfusion reactions between 1997 and 2007

2009 · B. Keller‐Stanislawski, A. Lohmann, et al. · Transfusion Medicine · 84

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

2009 · C. Micha Nübling, Margarethe Heiden, et al. · Transfusion · 74

Benefit of transfusion‐related acute lung injury risk‐minimization measures – German haemovigilance data (2006–2010)

2011 · M. B. Funk, S. Guenay, et al. · Vox Sanguinis · 63

Management of blood supplies during an influenza pandemic

2009 · Christel Kamp, Margarethe Heiden, et al. · Transfusion · 53

Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets

2011 · Michael Chudy, Marijke Weber‐Schehl, et al. · Transfusion · 51

Are quality differences responsible for different adverse reactions reported for SD‐plasma from USA and Europe?

2006 · U. Salge‐Bartels, S. Breitner‐Ruddock, et al. · Transfusion Medicine · 50

Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010)

2011 · Markus B. Funk, Annette Lohmann, et al. · Transfusion Medicine and Hemotherapy · 43

Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015)

2019 · Sarah A. Fiedler, Doris Oberle, et al. · Vox Sanguinis · 40

PDF

Sexual risk behaviour and donor deferral in Europe

2014 · R. Offergeld, C. Kamp, et al. · Vox Sanguinis · 40

Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures

2010 · G. Walther‐Wenke, C. H. Wirsing von König, et al. · Vox Sanguinis · 35

The Role of Inflammatory Cells and Their Proteases in Extravascular Fibrinolysis

1996 · Margarethe Heiden, Rainer Seitz, et al. · Seminars in Thrombosis and Hemostasis · 32

Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)

2015 · Markus B. Funk, Margarethe Heiden, et al. · Transfusion Medicine and Hemotherapy · 29

Quality and Safety in Blood Supply in 2010

2010 · Rainer Seitz, Margarethe Heiden · Transfusion Medicine and Hemotherapy · 29

The harmonization of the regulation of blood products: a European perspective

2008 · R. Seitz, M. Heiden, et al. · Vox Sanguinis · 28

Impact of hepatitis E virus testing on the safety of blood components in Germany – results of a simulation study

2018 · Christel Kamp, Johannes Blümel, et al. · Vox Sanguinis · 26

PDF

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany

2013 · Michael Chudy, Julia Kress, et al. · Transfusion Medicine and Hemotherapy · 25

Hämovigilanz in Deutschland – Berichte an das Paul-Ehrlich-Institut über Verdachtsfälle von Transfusionsreaktionen im Beobachtungszeitraum Januar 1995 bis Dezember 2002

2003 · A. Graul, M. Heiden, et al. · Transfusion Medicine and Hemotherapy · 25

Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)

2021 · Stefano Orru’, Kay Poetzsch, et al. · Transfusion Medicine and Hemotherapy · 23

PDF

Impact of vCJD on blood supply

2007 · Rainer Seitz, Friedger von Auer, et al. · Biologicals · 23

Plasma quality after whole‐blood filtration depends on storage temperature and filter type

2004 · M. Heiden, U. Salge, et al. · Transfusion Medicine · 23

Quality of therapeutic plasma—requirements for marketing authorization

2002 · Margarethe Heiden, Rainer Seitz · Thrombosis Research · 23

Hepatitis E Virus

2015 · The thermal stability of HEV has been investigated in cell culture systems using stool-derived HEV. Heat treatment at 45-50 °C for 1 h reduced the virus titres by a factor of 2, and incubation at 56 °C inactivated the virus completely [, et al. · Transfusion Medicine and Hemotherapy · 22

Inventory Management

2009 · D V Devine, G D Sher, et al. · Vox Sanguinis · 21

The growing number of hemophilia registries: Quantity vs. quality

2015 · C Keipert, J Hesse, et al. · Clinical Pharmacology & Therapeutics · 20

Works count: 116

Citation count: 1,267

H-index: 22

I10-index: 35